Climb Bio, Inc. <CLYM.O>: H.C. Wainwright Raises Target Price to $30 From $24
CLYM•Related News
American Healthcare REIT names Jon Crosier chief technology officer
AHR•
HSBC raises Brent crude price forecast to $90/bbl for 2026
XLE•
AppLovin Corporation <APP.O>: BTIG Cuts Target Price to $396 From $408
APP•
Facilities management firm ABM Industries' Q3 adj EPS beats on lower costs
ABM•
Compugen joins H.C. Wainwright Global Investment Conference fireside chat
CGEN•